SYN-TECH Chem. & Pharm. Co., Ltd.
1777.TWO
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.38B
Close$
Share Statistics
| Market cap | $3.38 Billion |
|---|---|
| Enterprise Value | $2.52 Billion |
| Dividend Yield | $4.00 (5.28%) |
| Earnings per Share | $5.87 |
| Beta | -0.06 |
| Outstanding Shares | 44,592,000 |
Return
| Return on Equity | 12.86% |
|---|---|
| Return on Assets | 10.47% |
| Return on Invested Capital | 14.25% |
Valuation & Multiples
| P/E Ratio | 10.17 |
|---|---|
| PEG | 2.29 |
| Price to Sales | 2.7 |
| Price to Book Ratio | 1.33 |
| Enterprise Value to Revenue | 1.98 |
| Enterprise Value to EBIT | 6.69 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$1.54
Average shareholder expectationRevenue Estimate
$233.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$1.54
Average shareholder expectationRevenue Estimate
$233.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About SYN-TECH Chem. & Pharm. Co., Ltd.
223 employees
CEO: Chun Cheng Hung SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, West...